Skip to content
A4225Assembly2019-2020 Session

Study Ibogaine for Addiction

Official title

“Relates to requiring the office of alcoholism and substance abuse services to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment”

Sponsor David WeprinAD-24Affects Health
Status
In Assembly Committee
Alcoholism And Drug Abuse
Impact
3/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Alcoholism And Drug Abuse

What's happening

This bill requires New York's Office of Alcoholism and Substance Abuse Services to support clinical research on using ibogaine for addiction treatment.

Why it matters

  1. Supports exploring alternative addiction treatments. By promoting research into ibogaine—a psychoactive substance with anecdotal evidence of effectiveness—New York could uncover new options for treating heroin, methamphetamine, and cocaine addiction, potentially improving outcomes for people struggling with substance use disorders.

  2. Signals openness to innovative and controversial therapies. Ibogaine is not currently an approved treatment in the U.S., and its use is debated due to possible risks. The bill’s support for research could help clarify safety, efficacy, and best practices, informing future policy and medical guidelines.

  3. Could influence broader drug policy and funding. If research shows positive results, it could lead to more attention, resources, and possibly changes in regulation around psychedelic-assisted therapies, impacting both state and national addiction treatment strategies.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Study Ibogaine for Addiction

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
David Weprin

Assembly Member · Assembly District 24

Chair, Insurance

No co-sponsors yet.

History

  1. Referred to alcoholism and drug abuse
  2. Referred to alcoholism and drug abuse

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

4225

2019-2020 Regular Sessions

IN ASSEMBLY

February 1, 2019

Introduced by M. of A. WEPRIN -- read once and referred to the Committee on Alcoholism and Drug Abuse

AN ACT to amend the mental hygiene law, in relation to requiring the office of alcoholism and substance abuse services to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 19.07 of the mental hygiene law is amended by adding a new subdivision (m) to read as follows:

(m) The office of alcoholism and substance abuse services shall encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.

§ 2. This act shall take effect immediately.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD08424-01-9

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.